These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
42. Use of intracavernosal alprostadil in erectile dysfunction. Gingell C Hosp Med; 1998 Oct; 59(10):777. PubMed ID: 9850293 [TBL] [Abstract][Full Text] [Related]
43. [Dionysos plaster or gunpowder without bullets]. Wolf HI Ugeskr Laeger; 2008 Apr; 170(16):1375; author reply 1375. PubMed ID: 18441605 [No Abstract] [Full Text] [Related]
44. Erectile dysfunction: the Viagra revolution. Harv Mens Health Watch; 2005 Apr; 9(9):1-6. PubMed ID: 18217258 [No Abstract] [Full Text] [Related]
45. [Positive for body and psyche]. Krankenpfl J; 2005; 43(4-6):153-4. PubMed ID: 16171097 [No Abstract] [Full Text] [Related]
46. What you need to know about erectile dysfunction. Nurs Times; 2005 Jan 25-31; 101(4):28. PubMed ID: 15719786 [No Abstract] [Full Text] [Related]
47. The causes of patient dropout from penile self-injection therapy for impotence. Mulhall JP; Jahoda AE; Cairney M; Goldstein B; Leitzes R; Woods J; Payton T; Krane RJ; Goldstein I J Urol; 1999 Oct; 162(4):1291-4. PubMed ID: 10492182 [TBL] [Abstract][Full Text] [Related]
48. Intracavernous injections for erectile dysfunction in patients with cardiovascular diseases and failure or contraindications for sildenafil citrate. Israilov S; Niv E; Livne PM; Shmueli J; Engelstein D; Segenreich E; Baniel J Int J Impot Res; 2002 Feb; 14(1):38-43. PubMed ID: 11896476 [TBL] [Abstract][Full Text] [Related]
49. [Treatment of erectile dysfunction]. Romics I Orv Hetil; 2004 Feb; 145(9):491-3. PubMed ID: 15077482 [No Abstract] [Full Text] [Related]
50. Treatment program for erectile dysfunction in patients with cardiovascular diseases. Israilov S; Baniel J; Shmueli J; Niv E; Engelstein D; Segenreich E; Livne PM Am J Cardiol; 2004 Mar; 93(6):689-93. PubMed ID: 15019870 [TBL] [Abstract][Full Text] [Related]
51. The effect of topically applied vasoactive agents and testosterone versus testosterone in the treatment of erectile dysfunction in aged men with low sexual interest. Gomaa A; Eissa M; El-Gebaley A Int J Impot Res; 2001 Apr; 13(2):93-9. PubMed ID: 11426345 [TBL] [Abstract][Full Text] [Related]
52. Penile rehabilitation after radical prostatectomy. Mehta A; Sigman M Med Health R I; 2009 Oct; 92(10):331-3. PubMed ID: 19911712 [No Abstract] [Full Text] [Related]
53. New classification system for erectile dysfunction therapies. Heaton J J Androl; 1998; 19(4):399-404. PubMed ID: 9733141 [No Abstract] [Full Text] [Related]
54. The Autoinjector device: an aid to intracavernosal pharmacotherapy. Gilbert HW; Gingell JC Br J Urol; 1992 Aug; 70(2):211-2. PubMed ID: 1393452 [No Abstract] [Full Text] [Related]
56. PNU-83757: a new agent for the treatment of erectile dysfunction. Carson CC Curr Urol Rep; 2002 Dec; 3(6):465-6. PubMed ID: 12425868 [No Abstract] [Full Text] [Related]
57. Alternatives to androgenic hormones in treating male impotency. Finkle AL; Thompson R Geriatrics; 1972 Aug; 27(8):74-6. PubMed ID: 5046546 [No Abstract] [Full Text] [Related]
58. Propranolol-induced impotency--correction of an error. Stoeckly VL Am J Hosp Pharm; 1981 Jan; 38(1):32-3. PubMed ID: 7211867 [No Abstract] [Full Text] [Related]
60. Behaviorism a factor in a case of suspected impotency. BECK JD Vet Ext Q; 1948 Apr; 3(110):10. PubMed ID: 18863482 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]